Endpoints News 生物医药· Kyle LaHucik·· 2026-10-16AI 评分35
City Therapeutics 完成 2 亿美元 IPO,构建 RNAi 领域 Alnylam 2.0
City Therapeutics lands $200M IPO as it builds an Alnylam 2.0 in RNAi field
AI 导读
City Therapeutics 即将于周五开始交易,成为 2026 年完成首次公开募股的第 26 家生物技术公司,融资 2 亿美元。该公司旨在 RNAi 领域打造类似 Alnylam 的企业。
正文
City Therapeutics will be the 26th biotech to complete an initial public offering in 2026 when it begins trading Friday morning, adding to a boisterous …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news